Our ZooMAb® recombinant antibodies platform represents an entirely new generation of recombinant monoclonal antibodies that offer the superior specificity and affinity of a monoclonal and polyclonal combined with the flexibility of a recombinant for a wider selection of targets, formats, and species.
Each ZooMAb® antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Each antibody is validated to reliably perform across multiple applications, including its most commonly used application.
Our first group of ZooMAb® antibodies are rabbit-derived, which can produce a large variety of desirable antibodies against “difficult” immunogens in mice, including small molecules (compounds of < 600 kDa), peptides, and antibodies specific for post-translational modification sites (PTM). By recognizing a higher diversity of epitopes per antigen at the picomolar level with high specificity, rabbit antibodies tend to provide excellent results in both standard assays and staining applications.
Every ZooMAb® antibody is provided as a lyophilized product, individually packaged to provide long-term stability, faster shipping, and minimize non-value-added costs that typically incur through cold chain handling of liquids, including the thermal insulated packaging used in transportation. Therefore, every ZooMAb® antibody is exceptionally stable to allow for ambient shipping and storage if needed.
Every ZooMAb® antibody is provided free of biocides like sodium azide or preservatives of animal origin, such as bovine serum albumin (BSA), and finished in a simple phosphate buffered saline (PBS) with trehalose. With ZooMAb® antibodies, complications arising from potentially hazardous materials or local safety restrictions are minimized and allow its use in both in vivo and in vitro applications.
Every ZooMAb® antibody is produced without the harm or sacrifice of animals. The proprietary recombinant expression system eliminates the need for arduous cell fusion and hybridoma construction, while providing greater specificity, affinity and reproducibility than monoclonal counterparts.
Every ZooMAb® antibody is pre-aliquoted at 25 µL lyophilized equivalents to maximize product shelf life. Hence, you only purchase what you need and resuspend what you will use for your research.
ZooMAb® antibodies are recombinantly produced, purified and pre-aliquoted for you. Every antibody is tested in our own laboratory to work in at least 3 applications and ensured to perform the way you would expect it to in western blotting, immunofluorescence, and other common applications.
Enhanced Validation-Recombinant Antibody Technology
Immunofluorescent analysis of NIH 3T3 cells was performed using a 1:100 dilution of Cat. No. ZRB001906, Anti-ATRX, clone 2A12, ZooMAb® Rabbit Monoclonal and visualized with a Goat Anti-Rabbit secondary antibody conjugated to Alexa Fluor® 488 (Green). Actin filaments have been labeled with phalloidin (Red). Nucleus is stained with DAPI (Blue). This antibody positively stains the nucleus.
Enhanced Validation-Recombinant Antibody Technology
Formalin Fixed Paraffin Embedded (FFPE) human prostate (A and B) tissue sections were prepared using heat-induced epitope retrieval (HIER). Immunostaining was performed using a 1:100 dilution of Cat. No. ZRB001906, Anti-ATRX, clone 2A12, ZooMAb® Rabbit Monoclonal. Reactivity was detected using a Goat Anti-Rabbit and DAB. Nuclear staining was observed in glandular cells of human prostate tissue sections.
The ZooMAb® recombinant monoclonal antibody platform has been awarded the ‘2020 Innovative Product of the Year’ by CiteAb, a leading life science data provider for citations and market data. We continue to push boundaries to help you make your next big discovery, vial after vial.
Use the convenient QR code printed on each ZooMAb® product label to find up to date information on all the newest additions to our ZooMAb® antibody portfolio and share your experience with these products. Our ZooMAb® antibodies are designed and tested with your needs in mind and are backed by our Antibody Guarantee.
We stand by the quality of our product with our Antibody Guarantee, if our antibody does not perform in applications described in our documentation, including product listings on our websites, catalogues or data sheets, we will issue a full credit or replacement antibody product.
Unless otherwise stated in the Product(s) specifications, any Antibody product is sold for internal research use only and may not be used for any other purpose, which includes but is not limited to, any commercial, diagnostic, or therapeutic use. Our validation processes pertain only to research uses and do not confirm or assure that our antibodies can be used for any unauthorized uses as set forth herein.
Research. Development. Production.
We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.